clarithromycin has been researched along with d-alpha tocopherol in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bagchi, D; Chatterjee, A; Stohs, SJ; Yasmin, T | 1 |
| Lu, Y; Tang, X; Wang, Y | 1 |
| Cui, S; Li, J; Nie, S; Pan, W; Wang, C; Yang, X | 1 |
| Çetinkaya, ZA; Coşgun, S; Güzelbulut, F; Kurdaş, OÖ; Sezikli, M; Yeşil, A | 1 |
| Aydoğdu, S; Baran, M; Çakır, M; Tümgör, G; Yüksekkaya, HA | 1 |
| Bilici, M; Demirci, H; Köktürk, F; Kurt, Ö; Öztürk, K; Üstündağ, Y; Uygun İlikhan, S; Uygun, A | 1 |
| Ahmed, F; Gul, Q; Imran, M; Shah, I; Shah, MR; Shah, SWA; Shoaib, M; Ullah, S | 1 |
1 review(s) available for clarithromycin and d-alpha tocopherol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for clarithromycin and d-alpha tocopherol
| Article | Year |
|---|---|
Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Ascorbic Acid; Clarithromycin; Combined Modality Therapy; Dietary Supplements; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Lansoprazole; Male; Middle Aged; Outpatient Clinics, Hospital; Proton Pump Inhibitors; Turkey; Vitamin E | 2012 |
Comparison of standard and standard plus vitamin E therapy for Helicobacter pylori eradications in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Antioxidants; Breath Tests; Child; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Prospective Studies; Proton Pump Inhibitors; Vitamin E | 2014 |
6 other study(ies) available for clarithromycin and d-alpha tocopherol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antimicrobial effects of antioxidants with and without clarithromycin on Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antioxidants; Ascorbic Acid; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Microbial Sensitivity Tests; Stilbenes; Time Factors; Urease; Vitamin E | 2005 |
Formulation and thermal sterile stability of a less painful intravenous clarithromycin emulsion containing vitamin E.
Topics: Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clarithromycin; Drug Stability; Emulsions; Hot Temperature; Injections, Intravenous; Pain; Particle Size; Rabbits; Rats; Rats, Wistar; Sterilization; Vitamin E; Vitamins | 2008 |
Optimization of tocol emulsions for the intravenous delivery of clarithromycin.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Drug Stability; Drug Storage; Emulsions; Excipients; Infusions, Intravenous; Microdialysis; Oleic Acid; Pain; Particle Size; Poloxamer; Rabbits; Sodium Hydroxide; Tocopherols; Vitamin E | 2008 |
Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Ascorbic Acid; Breath Tests; Clarithromycin; Dietary Supplements; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Organometallic Compounds; Retrospective Studies; Treatment Outcome; Vitamin E; Vitamins; Young Adult | 2015 |
Hydrophilically modified self-assembling α-tocopherol derivative as niosomal nanocarrier for improving clarithromycin oral bioavailability.
Topics: Administration, Oral; alpha-Tocopherol; Animals; Biological Availability; Clarithromycin; Drug Carriers; HeLa Cells; Humans; Liposomes; Male; Mice; Nanoparticles; NIH 3T3 Cells | 2018 |